Drug Profile
RO 6799477
Alternative Names: RO-6799477Latest Information Update: 30 Oct 2021
Price :
$50
*
At a glance
- Originator Roche
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Type 2 diabetes mellitus
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for phase-I development in Type-2-diabetes-mellitus in Netherlands (PO)
- 01 Dec 2014 Roche completes a phase I trial in Type-2 diabetes mellitus in the Netherlands (NCT02164266)
- 31 Jul 2014 Roche initiates enrolment in a phase I trial for Type-2 diabetes mellitus in the Netherlands (NCT02164266)